| PMID |
17105868 ( ![]() ![]() ![]() ) |
|---|---|
| Title | Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. |
| Abstract | The Fas pathway and oxidative stress mediate neuronal death in stroke and may contribute to neurodegenerative disease. We tested the hypothesis that these two factors synergistically produce spinal motor neuron degeneration in amyotrophic lateral sclerosis (ALS). Levels of reactive oxygen species were increased in motor neurons from ALS mice compared with wild-type mice at age 10 weeks, before symptom onset. The proapoptotic proteins Fas, Fas-associated death domain, caspase 8, and caspase 3 were also elevated. Oral administration of 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid (Neu2000), a potent antioxidant, blocked the increase in reactive oxygen species but only slightly reduced activation of proapoptotic proteins. Administration of lithium carbonate (Li(+)), a mood stabilizer that prevents apoptosis, blocked the apoptosis machinery without preventing oxidative stress. Neu2000 or Li(+) alone significantly enhanced survival time and motor function and together had an additive effect. These findings provide evidence that jointly targeting oxidative stress and Fas-mediated apoptosis can prevent neuronal loss and motor dysfunction in ALS. Korea 442-749. |
NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.
Targets by SciMiner Summary
| HUGO ID | Symbol | Target Name | #Occur | ActualStr |
|---|---|---|---|---|
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | 32 | Fas | Fas-signaling | Fas-associated | |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | 17 | caspase 3 | |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | 13 | caspase 8 | caspase-8 | |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | 12 | FADD | |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | 10 | Bcl-2 | bcl 2 | |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 9 | SOD1 | SOD | superoxide dismutase | |
| 8024 | NTF4 | neurotrophin 4 | 4 | NT-4 | nt 4/5 | NT-4/5 | |
| 26515 | COQ10A | coenzyme Q10 homolog A (S. cerevisiae) | 2 | coenzyme q10 a | Q10 | |
| 727 | ARTN | artemin | 2 | neurotrophic factor | |
| 8023 | NTF3 | neurotrophin 3 | 2 | neurotrophin 3 | NT-3 | |
| 1033 | BDNF | brain-derived neurotrophic factor | 2 | brain derived neurotrophic factor | |
| 391 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 1 | Akt-1 | |
| 19986 | CYCS | cytochrome c, somatic | 1 | cytochrome c | |
| 5464 | IGF1 | insulin-like growth factor 1 (somatomedin C) | 1 | insulin like growth factor 1 | |
| 1511 | CASP9 | caspase 9, apoptosis-related cysteine peptidase | 1 | caspase 9 | |
| 21354 | TICAM2 | toll-like receptor adaptor molecule 2 | 1 | cytoplasmic adaptor | |
| 15917 | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) | 1 | phospholipase c | |
| 592 | XIAP | X-linked inhibitor of apoptosis | 1 | XIAP | |
| 11936 | FASLG | Fas ligand (TNF superfamily, member 6) | 1 | fas ligand | |
| 14874 | NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 | 1 | nadph oxidase | |
| 7808 | NGF | nerve growth factor (beta polypeptide) | 1 | nerve growth factor | |
| 8975 | PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 1 | phosphatidylinositol 3 kinase | |
Targets by SciMiner Full list
| HUGO ID | Symbol | Name | ActualStr | Score | FlankingText |
|---|---|---|---|---|---|
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | The Fas pathway and oxidative stress mediate neuronal death in stroke and |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | The proapoptotic proteins Fas Fas-associated death domain caspase 8 and caspase 3 were also |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas-associated | 2.1 | The proapoptotic proteins Fas Fas-associated death domain caspase 8 and caspase 3 were also elevated |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 1.3 | The ratio of apoptotic cell death genes Bax to Bcl-2 is increased at both the mRNA and protein level in |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 1.3 | spinal cord mitochondria but not liver mitochondria and binds to Bcl-2 (Pasinelli Pasinelli et al. 2004 |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 1.3 | Altered expression and dysfunction of Bcl-2 may contribute to the activation of mitochondrial apoptosis machinery such |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 1.3 | In support of this idea overexpression of Bcl-2 or the caspase inhibitory protein XIAP prolongs survival and improves |
| 592 | XIAP | X-linked inhibitor of apoptosis | XIAP | 1.1 | this idea overexpression of Bcl-2 or the caspase inhibitory protein XIAP prolongs survival and improves motor performance in ALS mice expressing |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | G93A transgenic mice carrying the G93A human SOD1 mutation were obtained from the Jackson Laboratory (Bar Bar Harbor |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | In experiments investigating oxidative stress and activation of the Fas pathway mice received Neu2000 (30 30 mg/kg/day), mg kg day |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | The following primary antibodies were used Fas FADD (BD BD Bioscience Franklin Lakes NJ cleaved caspase 3 |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | The following primary antibodies were used Fas FADD (BD BD Bioscience Franklin Lakes NJ cleaved caspase 3 and |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | These mechanisms include mitochondrial dysfunction SOD1 mutations and activation of Ca -permeable ionotropic glutamate receptors which |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | and point mutations in the Cu Zn superoxide dismutase ( SOD1 gene the last of which are present in approximately 20% |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | Two findings in particular suggest a strong link between the SOD1 gene mutation and oxidative stress |
| 26515 | COQ10A | coenzyme Q10 homolog A (S. cerevisiae) | Q10 | 0.9 | (transgenic transgenic ALS mice administration of antioxidants such as coenzyme Q10 a component of the mitochondrial respiratory chain and creatine an |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | This raises the possibility that the SOD1 mutation not only enhances oxidative stress in lumbar motor neurons |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 2.4 | The latter effect may be attributable to interaction of mutant SOD1 and Bcl-2 causing mitochondrial dysfunction and subsequently increased sensitivity to |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | Bcl-2 | 1.3 | effect may be attributable to interaction of mutant SOD1 and Bcl-2 causing mitochondrial dysfunction and subsequently increased sensitivity to oxidative stress |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | We found that expression of Fas and FADD were increased selectively in the ventral motor neurons |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | We found that expression of Fas and FADD were increased selectively in the ventral motor neurons of G93A |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas-signaling | 1.8 | In motor neurons of ALS mice the Fas-signaling pathway remained activated after complete blockade of oxidative stress by |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | In support of this Li blocked activation of the Fas pathway during serum deprivation-induced apoptosis and attenuated motor neuron degeneration |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | and attenuated motor neuron degeneration as well as activation of Fas caspase 8 and caspase 3 in the spinal cords of |
| 391 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | Akt-1 | 0.0 | that result in activation of the serine/threonine serine threonine kinase Akt-1 and phospholipase C gamma (Chalecka-Franaszek Chalecka-Franaszek and Chuang 1999 ~0.425 |
| 8023 | NTF3 | neurotrophin 3 | NT-3 | 1.3 | neurotrophins nerve growth factor brain-derived neurotrophic factor neurotrophin 3 (NT-3), NT-3 and NT-4/5 NT-4 5 promote neuronal survival by preventing programmed |
| 8024 | NTF4 | neurotrophin 4 | NT-4/5 | 1.3 | growth factor brain-derived neurotrophic factor neurotrophin 3 (NT-3), NT-3 and NT-4/5 NT-4 5 promote neuronal survival by preventing programmed cell death |
| 8024 | NTF4 | neurotrophin 4 | NT-4 | 1.3 | factor brain-derived neurotrophic factor neurotrophin 3 (NT-3), NT-3 and NT-4/5 NT-4 5 promote neuronal survival by preventing programmed cell death or |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | conclusion the present study suggests that oxidative stress and the Fas death pathway constitute two separate routes of the motor neuron |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | The Fas pathway is slowly activated even in the blockade of oxidative |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Thus targeting both oxidative stress and the Fas apoptosis pathway with concurrent treatment with Neu2000 and Li may |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | A Western blot analysis showing expression of Fas FADD and actin in lumbar segments from control or G93A |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | A Western blot analysis showing expression of Fas FADD and actin in lumbar segments from control or G93A transgenic |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Levels of Fas (b) b and FADD (c) c were measured and scaled |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | Levels of Fas (b) b and FADD (c) c were measured and scaled to actin mean _amp_#177 |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | Western blot analysis of FADD and Fas after immunoprecipitation with Fas antibody in the same |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Western blot analysis of FADD and Fas after immunoprecipitation with Fas antibody in the same samples shown |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Western blot analysis of FADD and Fas after immunoprecipitation with Fas antibody in the same samples shown above (d) d |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | (b) b at 12 weeks of age after immuno-labeling with Fas antibody |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Note increased levels of Fas in the motor neurons (arrows) arrows from G93A mice |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase-8 | 3.0 | C Western blot analysis showing expression of cleaved caspase-8 cleaved caspase-3 and actin in lumbar segments from control or |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | C Western blot analysis of FADD after immunoprecipitation (IP) IP with Fas antibody cleaved caspase 8 |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Western blot analysis of FADD after immunoprecipitation (IP) IP with Fas antibody cleaved caspase 8 cleaved caspase 3 and actin in |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | F Western blot analysis of Fas FADD cleaved caspase 8 cleaved caspase 3 and actin in |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | F Western blot analysis of Fas FADD cleaved caspase 8 cleaved caspase 3 and actin in lumbar |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Fas- and Fas ligand-mediated apoptosis plays a role in neuronal loss in animal |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | We examined whether the Fas pathway would mediate apoptosis in ALS mice |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Expression of Fas and its cytoplasmic adaptor protein FADD and Fas-FADD interaction were |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | Expression of Fas and its cytoplasmic adaptor protein FADD and Fas-FADD interaction were also increased in the lumbar spinal |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Immunohistochemistry revealed that Fas expression was increased selectively in large spinal motor neurons of |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | These findings suggest that Fas FADD caspase 8 and caspase 3 are activated in spinal |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | These findings suggest that Fas FADD caspase 8 and caspase 3 are activated in spinal motor |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas-signaling | 1.8 | No activation of the Fas-signaling molecules in G93A mice was detectable at 16 weeks of |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | We also investigated whether serum deprivation would activate the Fas apoptosis pathway and whether this activation was sensitive to Li |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | Interaction of FADD with Fas cleaved caspase 8 and cleaved caspase 3 were |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Interaction of FADD with Fas cleaved caspase 8 and cleaved caspase 3 were all increased |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | the diet slightly but statistically insignificantly attenuated the increase in Fas FADD and cleaved caspase 8 and caspase 3 in the |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | diet slightly but statistically insignificantly attenuated the increase in Fas FADD and cleaved caspase 8 and caspase 3 in the lumbar |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | noteworthy that daily administration of Li completely blocked activation of Fas and its downstream mediators in G93A mice |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas | 2.9 | Neu2000 can block both oxidative stress and activation of the Fas apoptosis pathway induced in the spinal cords of G93A mice |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD | 1.9 | DIV days in vitro BSO DL -buthionine- S R -sulfoximine SOD superoxide dismutase LDH lactate dehydrogenase FADD Fas-associated death domain |
| 3573 | FADD | Fas (TNFRSF6)-associated via death domain | FADD | 1.4 | -buthionine- S R -sulfoximine SOD superoxide dismutase LDH lactate dehydrogenase FADD Fas-associated death domain |
| 11920 | FAS | Fas (TNF receptor superfamily, member 6) | Fas-associated | 2.1 | S R -sulfoximine SOD superoxide dismutase LDH lactate dehydrogenase FADD Fas-associated death domain |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | the proapoptotic proteins fas fas associated death domain caspase 8 and caspase 3 were also elevated. |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | the proapoptotic proteins fas fas associated death domain caspase 8 and caspase 3 were also elevated. |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | the ratio of apoptotic cell death genes bax to bcl 2 is increased at both the mrna and protein level in spinal motor neurons from patients with als and from sod1 g93a mice mu et al. 1996 ; vukosavic et al. 1999 . |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | mutant sod1 g93a has been observed to aggregate in spinal cord mitochondria but not liver mitochondria and binds to bcl 2 pasinelli et al. 2004 . |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | altered expression and dysfunction of bcl 2 may contribute to the activation of mitochondrial apoptosis machinery such as caspase 9 caspase 3 and cytochrome c in spinal motor neurons of als transgenic mice and humans with als guegan et al. 200 |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | altered expression and dysfunction of bcl 2 may contribute to the activation of mitochondrial apoptosis machinery such as caspase 9 caspase 3 and cytochrome c in spinal motor neurons of als transgenic mice and humans with als guegan et al. 2001 ; inoue et al. 2003 . |
| 1511 | CASP9 | caspase 9, apoptosis-related cysteine peptidase | caspase 9 | 1.0 | altered expression and dysfunction of bcl 2 may contribute to the activation of mitochondrial apoptosis machinery such as caspase 9 caspase 3 and cytochrome c in spinal motor neurons of als transgenic mice and humans with als guegan et al. 2001 ; inoue et al. 2003 . |
| 19986 | CYCS | cytochrome c, somatic | cytochrome c | 1.0 | altered expression and dysfunction of bcl 2 may contribute to the activation of mitochondrial apoptosis machinery such as caspase 9 caspase 3 and cytochrome c in spinal motor neurons of als transgenic mice and humans with als guegan et al. 2001 ; inoue et al. 2003 . |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | in support of this idea overexpression of bcl 2 or the caspase inhibitory protein xiap prolongs survival and improves motor performance in als mice expressing the sod1 g93a mutation kostic et al. 1997 ; inoue et al. 2003 . |
| 5464 | IGF1 | insulin-like growth factor 1 (somatomedin C) | insulin like growth factor 1 | 1.0 | surprisingly insulin like growth factor 1 prevents neuronal cell apoptosis and protects spinal motor neurons in als mice ryu et al. 1999 ; kaspar et al. 2003 but markedly potentiates neuronal cell necrosis induced by hydroxyl radical or glut |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | ctions were then reacted overnight at 4degreec with the primary antibodies: mouse anti fas bd biosciences san jose ca anti nitrotyrosine 4 microg/ml; upstate biotechnology lake placid ny anti cleaved caspase 3 cell signaling technology danvers ma and anti neun. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | the following primary antibodies were used: fas fadd bd bioscience franklin lakes nj cleaved caspase 3 and cleaved caspase 8 1 microg/ml; cell signaling technology . |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | the following primary antibodies were used: fas fadd bd bioscience franklin lakes nj cleaved caspase 3 and cleaved caspase 8 1 microg/ml; cell signaling technology . |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | superoxide dismutase | 1.0 | oxidative stress in als seems to be attributable to multiple factors including mitochondrial dysfunction reduced glutathione peroxidase activity and point mutations in the cu zn superoxide dismutase sod1 gene the last of which are present in approximately 20% of familial als cases rosen et al. 1993 . |
| 26515 | COQ10A | coenzyme Q10 homolog A (S. cerevisiae) | coenzyme q10 a | 1.0 | second in transgenic mice expressing the sod1 g93a mutation transgenic als mice administration of antioxidants such as coenzyme q10 a component of the mitochondrial respiratory chain and creatine an inhibitor of the mitochondrial transition pore reduces free radical formation and increases life span and motor performance matthews e |
| 990 | BCL2 | B-cell CLL/lymphoma 2 | bcl 2 | 1.0 | the latter effect may be attributable to interaction of mutant sod1 and bcl 2 causing mitochondrial dysfunction and subsequently increased sensitivity to oxidative stress pasinelli et al. 2004 . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | we found that expression of fas and fadd were increased selectively in the ventral motor neurons of g93a transgenic mice and that this led to activation of caspase 8 and caspase 3. |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | we found that expression of fas and fadd were increased selectively in the ventral motor neurons of g93a transgenic mice and that this led to activation of caspase 8 and caspase 3. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | in support of this li blocked activation of the fas pathway during serum deprivation induced apoptosis and attenuated motor neuron degeneration as well as activation of fas caspase 8 and caspase 3 in the spinal cords of als mice. |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | in support of this li blocked activation of the fas pathway during serum deprivation induced apoptosis and attenuated motor neuron degeneration as well as activation of fas caspase 8 and caspase 3 in the spinal cords of als mice. |
| 8975 | PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | phosphatidylinositol 3 kinase | 1.0 | 0 blocks free radical neurotoxicity in cortical cell cultures at a dose as low as 0.3 microm and completely blocks free radical production after focal cerebral gwag et al. 2006 beta and activation of phosphatidylinositol 3 kinase that result in activation of the serine/threonine kinase akt 1 and phospholipase c gamma chalecka franaszek and chuang 1999 ~0.425 _amp_#177; 0.05 meq/l in blood below the therapeutic range 0.6 1.5 m |
| 15917 | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) | phospholipase c | 1.0 | completely blocks free radical production after focal cerebral gwag et al. 2006 beta and activation of phosphatidylinositol 3 kinase that result in activation of the serine/threonine kinase akt 1 and phospholipase c gamma chalecka franaszek and chuang 1999 ~0.425 _amp_#177; 0.05 meq/l in blood below the therapeutic range 0.6 1.5 meq/l in blood for treatment of manic episodes and depression in humans ross and fra |
| 727 | ARTN | artemin | neurotrophic factor | 1.0 | long term treatment with li increases expression of brain derived neurotrophic factor in the hippocampus and neocortex which mediates the antiapoptotic action of li fukumoto et al. 2001 . |
| 1033 | BDNF | brain-derived neurotrophic factor | brain derived neurotrophic factor | 1.0 | long term treatment with li increases expression of brain derived neurotrophic factor in the hippocampus and neocortex which mediates the antiapoptotic action of li fukumoto et al. 2001 . |
| 727 | ARTN | artemin | neurotrophic factor | 1.0 | the neurotrophins nerve growth factor brain derived neurotrophic factor neurotrophin 3 nt 3 and nt 4/5 promote neuronal survival by preventing programmed cell death or apoptosis but they markedly enhance necrotic degeneration of neurons exposed to oxidative stress koh et |
| 8023 | NTF3 | neurotrophin 3 | neurotrophin 3 | 1.0 | the neurotrophins nerve growth factor brain derived neurotrophic factor neurotrophin 3 nt 3 and nt 4/5 promote neuronal survival by preventing programmed cell death or apoptosis but they markedly enhance necrotic degeneration of neurons exposed to oxidative stress koh et al. 1995 ; won |
| 7808 | NGF | nerve growth factor (beta polypeptide) | nerve growth factor | 1.0 | the neurotrophins nerve growth factor brain derived neurotrophic factor neurotrophin 3 nt 3 and nt 4/5 promote neuronal survival by preventing programmed cell death or apoptosis but they markedly enhance necrotic degeneration of neurons |
| 8024 | NTF4 | neurotrophin 4 | nt 4/5 | 1.0 | the neurotrophins nerve growth factor brain derived neurotrophic factor neurotrophin 3 nt 3 and nt 4/5 promote neuronal survival by preventing programmed cell death or apoptosis but they markedly enhance necrotic degeneration of neurons exposed to oxidative stress koh et al. 1995 ; won et al. 2000 . |
| 8024 | NTF4 | neurotrophin 4 | nt 4/5 | 1.0 | the neurotrophins nerve growth factor brain derived neurotrophic factor neurotrophin 3 nt 3 and nt 4/5 promote neuronal survival by preventing programmed cell death or apoptosis but they markedly enhance necrotic degeneration of neurons exposed to oxidative stress koh et al. 1995 ; won et al. 2000 . |
| 1033 | BDNF | brain-derived neurotrophic factor | brain derived neurotrophic factor | 1.0 | the neurotrophins nerve growth factor brain derived neurotrophic factor neurotrophin 3 nt 3 and nt 4/5 promote neuronal survival by preventing programmed cell death or apoptosis but they markedly enhance necrotic degeneration of neurons exposed to oxidative stress koh et |
| 14874 | NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 | nadph oxidase | 1.0 | neurotrophins can induce oxidative stress through up regulation of nadph oxidase leading to neuronal cell necrosis kim et al. 2002 kim et al. 2002 . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | c western blot analysis showing expression of cleaved caspase 8 cleaved caspase 3 and actin in lumbar segments from control or g93a mice at ages indicated a . |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | c western blot analysis showing expression of cleaved caspase 8 cleaved caspase 3 and actin in lumbar segments from control or g93a mice at ages indicated a . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | levels of cleaved caspase 8 b and caspase 3 c were measured and scaled to actin mean _amp_#177; s.e.m. |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | levels of cleaved caspase 8 b and caspase 3 c were measured and scaled to actin mean _amp_#177; s.e.m. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | d fluorescence photomicrographs of lumbar ventral sections from control a and g93a mice b at 12 weeks of age immunolabeled with an antibody for cleaved caspase 3. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | note activation of caspase 3 in the motor neurons arrows from g93a mice. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | c western blot analysis of fadd after immunoprecipitation ip with fas antibody cleaved caspase 8 cleaved caspase 3 and actin in neuron rich cortical cell cultures deprived of serum for 12 h alone or in the presence of 1 microm neu2000 or 5 mm li . |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | c western blot analysis of fadd after immunoprecipitation ip with fas antibody cleaved caspase 8 cleaved caspase 3 and actin in neuron rich cortical cell cultures deprived of serum for 12 h alone or in the presence of 1 microm neu2000 or 5 mm li . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | f western blot analysis of fas fadd cleaved caspase 8 cleaved caspase 3 and actin in lumbar segments from control and g93a transgenic mice treated with saline neu2000 30 mg/kg/days or li 200 mg/kg/days for 4 weeks starting from 8 weeks of age a . |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | f western blot analysis of fas fadd cleaved caspase 8 cleaved caspase 3 and actin in lumbar segments from control and g93a transgenic mice treated with saline neu2000 30 mg/kg/days or li 200 mg/kg/days for 4 weeks starting from 8 weeks of age a . |
| 11936 | FASLG | Fas ligand (TNF superfamily, member 6) | fas ligand | 1.0 | fas and fas ligand mediated apoptosis plays a role in neuronal loss in animal models of stroke martin et al. 2001 beta amyloid neurotoxicity in cultured cortical neurons su et al. 2003 . |
| 21354 | TICAM2 | toll-like receptor adaptor molecule 2 | cytoplasmic adaptor | 1.0 | expression of fas and its cytoplasmic adaptor protein fadd and fas fadd interaction were also increased in the lumbar spinal cord of g93a transgenic mice at 12 weeks of age compared with control mice fig 2a . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | increased expression of the apoptosis inducing signaling complex was followed by activation of caspase 8 and caspase 3 in the lumbar spinal cord fig 2c . |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | increased expression of the apoptosis inducing signaling complex was followed by activation of caspase 8 and caspase 3 in the lumbar spinal cord fig 2c . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | the active form of caspase 3 was observed in spinal motor neurons from g93a mice fig 2d . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | these findings suggest that fas fadd caspase 8 and caspase 3 are activated in spinal motor neurons and mediate subsequent neuronal apoptosis in als mice. |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | these findings suggest that fas fadd caspase 8 and caspase 3 are activated in spinal motor neurons and mediate subsequent neuronal apoptosis in als mice. |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | interaction of fadd with fas cleaved caspase 8 and cleaved caspase 3 were all increased in neuron rich cortical cell cultures deprived of serum for 8 h and these changes were blocked by the addition of li but not neu2000 fig 3c . |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | interaction of fadd with fas cleaved caspase 8 and cleaved caspase 3 were all increased in neuron rich cortical cell cultures deprived of serum for 8 h and these changes were blocked by the addition of li but not neu2000 fig 3c . |
| 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | caspase 3 | 1.0 | daily administration of neu2000 in the diet slightly but statistically insignificantly attenuated the increase in fas fadd and cleaved caspase 8 and caspase 3 in the lumbar spinal cords of g93a transgenic mice at 12 weeks of age fig 3f . |
| 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | caspase 8 | 1.0 | daily administration of neu2000 in the diet slightly but statistically insignificantly attenuated the increase in fas fadd and cleaved caspase 8 and caspase 3 in the lumbar spinal cords of g93a transgenic mice at 12 weeks of age fig 3f . |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | superoxide dismutase | 1.0 | abbreviations: als amyotrophic lateral sclerosis; page paw grip endurance; mfr mitochondrial free radicals; div days in vitro; bso dl buthionine [ s r ] sulfoximine; sod superoxide dismutase; ldh lactate dehydrogenase; fadd fas associated death domain. |